| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner, Passive Investor
1 company
Levin Capital Strategies, L.P. is a 10% Owner, Passive Investor at LAB. Recent filings cover 153 purchases and 0 sales. Those positions are worth an estimated $129K at current prices.
Levin Capital Strategies, L.P.'s largest disclosed position is in LAB as 10% Owner, Passive Investor, worth about $129K. Net of sales, the recent Form 4 record there shows accumulation of 3,370,360 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 17, 2017 | LAB Standard Biotools Inc. | 10% Owner, Passive Investor | Buy | 465 | $3.66 | $1,700.74 | - | |
| Aug 9, 2017 | LAB Standard Biotools Inc. | 10% Owner, Passive Investor | Buy | 1,549 | $3.18 | $4,931.71 | - | |
| Nov 7, 2016 | LAB Standard Biotools Inc. | 10% Owner, Passive Investor | Buy | 159,200 | $4.44 | $706,570.95 | +0.6% | |
| Nov 2, 2016 | LAB Standard Biotools Inc. | 10% Owner, Passive Investor | Buy | 48,302 | $4.44 | $214,531.27 | +0.3% |